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Summary 
Three studies, a pilot study with conventional 
early-weaned pigs and two studies with 
gnotobiotic pigs were completed. The pilot study 
indicated that conventional pigs could be 
challenged with at least 107 colony forming units 
(cfu) or Actinobaci/lus p/europneumonia (APP) or 
Actinobaci/Jus suis (A. suis) without developing 
clinical signs. No serological response was 
detected in these pigs. In the first gnotobiotic 
study, nine pigs were used: 3 control, 3 APP or 3 
A. suis. The two groups of challenged pigs 
failed to respond clinically or serologically to the 
initial challenge of 106 cfu of either APP or 
A. suis but the APP pigs did respond clinicall¥ 
and serologically to a second challenge of 10 
cfu. A second study with twenty gnotobiotic pigs 
was completed. Eight pigs were assigned to the 
Actinobaci/Jus p/europneumoniae (APP) serotype 
5 group; eight pigs were assigned to the 
Actinobacil/us suis (A. suis) group and 4 pigs 
were assigned to the control group. Each grouJ) 
of gnotobiotic pigs were challenged with 107 
colony forming units (cfu) of either APP or 
A. suis. In both gnotobiolic studies, serological 
tests indicated that the hemolysin neutralization 
test (HNT) specificity was poor as ii was unable 
lo discriminate between APP or A. suis 
infections. The HNT test detected more APP 
positive animals than any other test and detected 
APP infected animals one-month post challenge. 
In the first gnotobiotic study, APP infected pigs 
were detected at one-two weeks post challenge 
with the APP 5 ELISA developed by the 
University of Montreal (ELISA-M). ELISA-M was 
a more sensitive test than the APP 5 ELISA 
developed by Oxford Laboratories (ELISA-0). In 
the second gnotobiotic study, the ELISA-M and 
ELISA-0 failed to detect any APP 5 
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infected animals. In both gnotobiotic studies, the 
complement fixation test failed to detect any 
animals and was insensitive to APP infections. 
Introduction 
Serology is the tool of choice for determining 
exposure of animals to Actinobaci/Jus 
p/europneumonia (APP)'. A number of different 
tests are available including the hemolysin 
neutralization test (HNT), enzyme labeled 
immunosorbent assays (ELISA) and the 
complement fixation (CF) test. The cross 
reactivity between APP and Actinobaci/Jus suis 
(A. suis) has been thought to be confounding 
factor resulting in A. suis animals being identified 
as APP infected. The hemolysin RTX toxin of A. 
suis and APP serotype 5 have almost identical 
genetic, molecular and antigenic structure2•3·4 
and previous infections with A. suis can ,protect 
pigs against subsequent APP infections . The 
detection of A. suis and APP has been based on 
higher hemolysin neutralization antibodies with 
APP infected pigs than with A. suis infected pigs. 
This study was designed to follow the serological 
response as measured by HNT, ELISA 
developed by Dr. M. Gottschalk, University of 
Montreal (ELISA-M), ELISA developed by Oxford 
Laboratories (ELISA-0) and the CF test 
following infection with either APP serotype 5 or 
A. suis in gnotobiotic pigs. 
Experimental Approach 
Bacteria: An APP Type 5 culture and seven 
A. suis isolates (#5, 7, 9, 11, 12, 20 and 24) were 
received from Dr. James Collins, University of 
Minnesota. 
Animals: Pilot Study-Eight, 14 day old high 
health barrows were received from a PIC based 
genetics herd in western Minnesota. The pigs 
were divided into two groups of 4 and place in 
two separate rooms. One pig in the APP group 
died following the initial blood collection. The 
pigs were tagged and their temperatures 
recorded each day. Three pigs were the APP 
serotype 5 group and four pigs were the A. suis 
pigs. 
Gnotobiotic Studies: In the first gnotobiotic 
study, gnotobiotic surgery was performed on one 
sow. The gnotobiotic pigs were moved out of the 
isolettes. :rhree pigs in an isolette in APP Room, 
three pigs in an isolette in A. suis Room and 
three pigs in Control Room. 
In the second gnotobiotic experiment, 
gnotobiotic surgeries were performe,d on three 
sows. The gnotobiotic pigs were moved out of 
the isolettes at 23 days of age. Twenty pigs 
were then moved to three separate areas. Eight 
pigs in two isolettes in APP room, eight pigs in 
two isolettes in A. suis room and four pigs in one 
isolette in control room. 
In both gnotobiotic studies, the pigs were 
exposed to unfiltered air when the isolettes were 
opened in each room at 23 days of age. The 
gnotobiotic pigs were then fed a starter pellet 
containing Apralan ™ and treated with oral 
chlortetracycline at a rate of 1 O mg/lbs for 5 
days. The pigs were tagged and their 
temperatures recorded each day. After 4 days, 
the pigs were removed from the isolettes and 
placed on the floor. The pigs were kept on a 
pelleted diet for 2 weeks and then phased unto a 
non-medicated meal diet. 
Challenge: Pilot Study- Three pigs were 
inoculated intranasally with 1 ml of APP serotype 
5 using 1/2 ml/nostril: one pig with 1 ml of 
105 cfm/ml, one pig with 1 ml of 106 cfm/ml, and 
one pig with 1 ml of 107 cfm/ml. Four pigs in 
another isolation room were inoculated 
intranasally with A. suis: one ,p_ig with 1 ml of 
10
4 
cfm/ml, one with 1 ml of 10 cfm/ml, one with 
1 ml of 106 cfm/ml, and one with 1 ml of 
107 cfm/ml. The pigs were monitored for clinical 
signs twice daily for 14 days. 
Gnotobiotic Studies The gnotobiotic animals 
were challenged at 36-43 days of age. Prior to 
challenge, serum samples were collected from 
each pig. In Gnotobiotic Study 1, the three APP 
challenged pigs were each inoculated 
intranasally with Y:, ml/nostril (1 ml total) of 
106 cfu/ml of APP serotype 5. The three A. suis 
pigs were each inoculated with 1 ml of 106 cfu/ml 
of a mixture of A. suis isolates #9, #12, and #24. 
The two control pigs were inoculated with media. 
The pigs were monitored for clinical signs twice 
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daily for 14 days. No antibody titer was detected 
in these animals on weekly bleedings following 
challenge. On Day 42 post challenge, the pigs 
had their nasal passages re-swabbed for 
bacterial isolation, serum collected and pigs 
were re-inoculated using a 1 in. nasal cannula. 
The APP pigs were each inoculated intranasally 
with 1 ml of 107 cfu/ml of APP serotype 5 using 
1 /2 ml/nostril. The A. suis pigs were each 
inoculated with 1 ml of 107 cfu/ml of a mixture of 
A. suis isolates #9, #12, and #24 using 1/2 
ml/nostril. The two control pigs were inoculated 
with media. The pigs. were monitored for clinical 
signs twice daily for 7 days. 
For gnotobiotic study 2, eight pigs were 
individually inoculated intranasally with 1/2 ml 
per nares (1 ml total) of 107 cfu/ml of APP 
serotype 5. Eight pigs were each inoculated with 
1 ml of 107 cfu/ml of a mixture of A. suis isolates 
#9, #12, and #24. The four control pigs were 
inoculated with media. The pigs were monitored 
for clinical signs for 14 days (three times daily for 
9 days, twice· a day for 4 days and once a day for 
one day). The pigs were bled weekly for APP 
antibody titers. On day 54 after challenge, the 
pigs were re-inoculated as described above, 
The pigs were monitored for clinical signs twice 
daily for 7 days. The pigs were moved off-site on 
day 97 where the pigs were placed in separate 
nursery rooms and fed a commercial grow-finish 
diet and bled weekly to day 135 post-challenge. 
Clinical signs: In all three studies, clinical 
observations were made prior to challenge and 
for 7-14 days post challenge. 
Necropsy: In the pilot and gnotobiotic 
study 1, all animals were euthanized, necropsied· 
and tonsils and bronchial lymph nodes were 
cultured. In gnotobiotic study 2, only animals 
that.died were necropsied and cultured. 
Sample Collection: Blood samples were 
collected bi-weekly for the pilot study and weekly 
for the gnotobiotic studies by venipuncture. 
Nasal swabs were collected by ·restraining the 
pigs and swabbing each nostril with. a cotton 
tipped applicator. . These swabs were 
immediately submitted to the SDSU Diagnostic 
Laboratory Bacteriology Section for analysis. 
Serological Testing: At the end of each study 
2 ml of serum from each sampling was aliquoted 
into four 0.5 ml aliquots. One aliquot was then 
sent to Kansas State University for APP HNT. 
The cutoff for the HNT test were <3000 negative, 
3001-6000 suspect and >6000 were positive. A 
second aliquot was sent to Oxford Laboratories 
for APP serotype 5 ELISA titers (ELISA-0). The 
cutoff for the ELISA-0 was < 0.3 negative and 
>0.3 positive. A third aliquot was sent to 
University of Montreal for APP serotype 5 ELISA 
titers (ELISA-M). The cutoff for ELISA-M was 
<0.29 negative, 0.30-0.39 suspect and .0.40 
positive. The last sample was sent to Iowa State 
University for APP CF titers. 
Results 
Bacterial cultures: Identification of the 
challenge cultures submitted to the SDSU 
Bacteriology Section indicated the cultures were 
APP and A. suis. Pre-challenge nasal swabs 
from all the studies had normal bacterial flora. 
Clinical signs and treatment: Pilot study 
None of the animals developed clinical signs. 
Gnotobiotic Study 1 
Control Pigs: There were no elevated 
temperatures or clinical scores throughout the 
study in this group. 
A. suis Group: There were no clinical signs 
in the A. suis group following either challenge. 
APP Group: Challenge 1: One pig had a 
temperature of 104.5 on day 4, and was treated 
once a day for three days with Naxcel · at 
2 mg/lbs. On day 7, this same pig developed a 
swollen left hock and was treated with Procaine 
Penicillin G at 10,000 units/lbs sid for 4 days. 
On day 9, the synovial space on the left hock 
was tapped for culture. Culture results found 
only a few fecal Streps. 
Challenge 2: On day 45 (3 days following the 
second challenge), three APP pigs developed a 
fever and were treated with Naxcel (ceftiofur 
hydrochloride, Pharmacia-Upjohn) at 2 mgnbs. 
On day 46, a fourth pig, who was an unthrifty pig, 
50% smaller than his cohorts, developed a fever 
and died. On day 56 one pig's head was swollen 
on the left side. The pig was treated with Naxcel 
at 2 mg/lbs. The pig returned to normal by the 
next day. 
Gnotobiotic Study 2. 
Control Group: Challenge 1: These pigs 
had slightly elevated body temperatures on day 5 
and 6 that returned to normal without treatment. 
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All pigs developed moderate diarrhea on days 7 
or 8. 
Challenge 2: There were no elevated 
temperatures or clinical scores throughout the 
one-week observation period. One pig 
developed a severe lameness and respiratory 
distress on day 118 and was treated with 
Procaine Penicillin G for three days (10,000 
units/lbs). 
A. suis Group: Challenge 1: One pig had an 
elevated body temperature on day 5 and day 6 
and two pigs had elevated body temperatures on 
days 7 and 13. One pig was slightly depressed 
and panting on day 2 and had moderate 
depression on day 13. This pig was treated on 
day 2 and two pigs were treated on day 13 with a 
single dose of Excenel (ceftiofur hydrochloride, 
Pharmacia-Upjohn) at 2 mg/lbs intramuscularly. 
One pig died on day 23. 
Challenge 2: There were no elevated 
temperatures or clinical scores throughout the 
one-week observation period. 
APP Group: Challenge 1: One pig had an 
elevated body temperature on days 4 and 6 and 
two pigs had an elevated body temperature on 
day 6. Six of the APP group exhibited moderate 
to severe depression ·on day 5. One pig ·died on 
day 6 and one pig died on day 7. The remaining· 
6 pigs were treated for 4 days with Excenel at 
2 mg/lbs intramuscularly on days 7-10. 
Challenge 2: There were no elevated 
temperatures throughout the one week 
observation. One pig developed moderate 
depression on days 60-62 (10-12 days following 
second challenge). 
Necropsy results: Pilot study: There were no 
gross lesions in any of the pigs. Bacterial 
cultures from the tonsil and bronchial lymph 
nodes contained normal bacterial flora with the 
exception of one pig that had a Streptoccus suis 
isolation (data not shown). 
Gnotobiotic Study 1 
All pigs were necropsied at day 90 unless 
otherwise noted. There were no gross lesions or 
significant bacteria in the control pigs. 
A. suis group: One pig had adhesive 
pericarditis but no bacteria was isolated. 
Bacterial cultures of the tonsil and bronchial 
lymph node of the A. suis group were negative. 
APP group: The necropsy of the pig that 
died on day 46 indicated that the animal was 
emaciated and only hemolytic E.coli was isolated · 
from the intestine and no bacteria were isolated 
from the lung or pericardium. One pig had a 
focal abscess in the left lung. The right apical 
lobe of the lung was adhered to the pericardia! 
sac. The heart had chronic adhesive 
pericarditis. No bacteria were isolated from 
these lesions. Bacterial cultures of the tonsil and 
bronchial lymph node were negative. 
Gnotobiotic Study 2 
Only pigs that died were necropsied. 
A. suis group: One pig that died on day 23 
was necropsied. This pig had a reddening of the 
left-middle lung lobe. A. suis was isolated in 
heavy growth from lung and liver. No other 
pathogens were isolated. 
APP 5 Group: Two pigs were necropsied. 
Both pigs had pleuritis, peritonitis and 
pericarditis. This was characterized by 
fibrinopurulent exudate. Pure cultures of APP 
were isolated from both pigs. No other 
pathogens were isolated. 
Serology 
Pilot study: No serological titers developed in 
any pig at any time point. 
Gnotobiotic Study 1: 
Control pigs: The control pigs developed no 
APP serological titers (data not shown). 
A. suis pigs: No APP titers were detected 
with any test until following the second 
challenge. All three pigs developed HNT 
following the second challenge. Two pigs 
developed HNT 3 weeks following re-infection 
(Table 1 ). These titers increased in both pigs in 
subsequent weeks and the final titer in the pigs 
was comparable to titers seen with the APP 
infected pigs. One pig developed a HNT one 
month after re-infection and this titer increased in 
the last week of the experiment (Table 1 and 3). 
The A. suis pigs developed no titers detected by 
either ELISA test (ELISA-M or ELISA-OJ or 
complement fixation (CF) (Table 1 ). 
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APP: No App titers were detected with any 
test until following the second challenge. The 
APP HNT test detected all three APP-infected 
pigs (Table 2). The first pig was detected by two 
weeks post challenge and by one month for all 
three pigs (Table 2). Two of APP pigs, 
developed ELISA titers (Table 2). One pig's 
APP titer was detected by both ELISA tests. The 
average HNT titers for the APP group were 
higher than those for the A. suis group (Table 3). 
The ELISA-M test detected APP titers one week 
after infection compared to two weeks with the 
ELISA-0. The ELISA-M detected one more pig 
than the ELISA-0. This was detected two weeks 
post challenge. One pig was negative by both 
APP ELISA tests. This pig approached the 
ELISA-M cutoff of 0.30 but was always below it. 
The CF test did not detect any serological 
positive animals (Table 2). 
Gnotobiotic Study 2 
Control pigs: One pig developed positive 
HNT titers at day 126. This was 10 days after 
this pig developed severe respiratory signs and 
lameness. At day 135, all four control pigs were 
HNT positive with an average HNT of 9908. The 
other three APP serology tests were negative at 
all time points for all pigs (data not shown). 
A. suis Group: HNT test detected all of A. 
suis challenged animals. The first detection 
was on day 21 in 1 of 6 animals. At day 28, 4 of 
7 animals were positive;at days 35and 42, 6 of 7 
were positive; and at day 49, 7 of 7 animals 
were positive (Table 4). These titers continued 
to increase in most animals at levels higher than 
that seen with APP (Table 6). The HNT levels 
were still high at the end of the study (Table 6). 
ELISA-M did not detect any positive animals 
using the cutoff of 0.3 (Table 3). Titers were 
consistently at background throughout the study. 
The ELISA-0 did not detect any suspect or 
positive animals using their S/P cutoff of 0.3 
(Table 4). All of the pigs were at background 
levels. APP 5 CF test did not detect any positive 
pigs throughout the study period (Table 4). 
APP Group: HNT test detected APP 5 
seropositive animals. The first detection was 
made on day 42 in 1 of 6 animals (Table 5). By 
day 49, 2 of 6 animals were positive and by day 
56, 6 of 6 animals were positive (Table 5). 
These titers continued to increase in most 
animals and then they began to decline by the 
end of the study (Table 6). All animals were still 
seropositive at the end of the study (Table 5). 
APP 5 ELISA·M did not detect any suspect or 
positive animals using the cutoff of 0.3 (Table 5). 
The APP 5 ELJSA-0 did not detect any positive 
animals (Table 5). APP 5 CF test did not detect 
any pigs throughout the study period (Table 5). 
Discussion 
Three major conclusion were reached with 
the two gnotobiotic studies: 1) the specificity of 
the HNT test is poor; 2) the sensitivity of the 
tests in rank from highest to lowest is: 
HNT>ELISA·M>ELISA-0; and 3) the CF test 
was totally insensitive in this experiment. In 
these experiments it is clear that the HNT can 
not discriminate between A. suis or APP infected 
pigs. This is not suprising considering how 
closely the RTX toxin is related between the two 
species of bacteria2•3•4. In the first experiment, 
the highest HNT liters in either group were in the 
animals that developed the most severe 
pathological lesions. This is also true for the 
ELISA·M test where the highest values were 
seen in the APP animal with severe lesions and 
this was the only animal detected by the ELISA· 
0. The use of therapeutic antibiotics in one of 
the APP animals probably prevented this pig 
from developing a high immune response. In 
the second experiment, the A. suis pigs had 
higher HNT titers than the APP challenged pigs 
(Table 6). 
A problem in this first experiment was 
developing a consistent challenge model. 
Because of the unknown pathogenesis of APP 
and A. suis in gnotobiotic pigs, a very 
conservative approach was taken. It is clear that 
at least 107 cfu of APP are needed in gnotobiotic 
pigs to cause disease. The use of a intranasal 
cannula for inoculation also maybe important. A 
third consideration is minimizing the use of 
antibiotics in the feed or water as these could 
have hampered the first challenge in the 
gnotobiotic pigs. From the knowledge gained 
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TABLE 1 SEROLOGY GNOTOBIOTIC PIGS TRIAL 1-A. SUIS* 
Day HNT' ELISA-M
2 
O Challenge 1 0/3 0/3 
7 0/3 0/3 
14 0/3 0/3 
21 0/3 0/3 
28 0/3 0/3 
35 0/3 0/3 
42 Challenge 2 0/3 0/3 
49 0/3 0/3 
56 0/2# 0/3 
63 2/3 0/3 
71 3/3 0/3 
78 3/3 0/3 
*number of pigs positive/total number of pigs. 
1Hemolysin Neutralization Titer-Kansas State University 
2 APP 5 ELISA-University of Montreal 
3APP 5 ELISA-Oxford Laboratories 
4APP 5 Complement Fixation-Iowa State University 
# one sample was not tested 
ELISA-03 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
TABLE 2 SEROLOGY GNOTOBIOTIC PIGS TRIAL 1-APP* 
Day 
O Challenge 1 
7 
14 
21 
28 
35 
42 Challenge 2 
49 
56 
63 
71 
78 
HNT' 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
1/3 
1/3 
3/3 
3/3 
ELISA-M2 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
1/3 
2/3 
2/3 
2/3 
2/3 
*Number of pigs positive/total number of pigs. 
1Hemolysin Neutralization Titer-Kansas State University. 
2 APP 5 ELISA-University of Montreal. 
3 APP 5 ELISA-Oxford Laboratories. 
4APP 5 Complement Fixation-Iowa State University. 
141 
ELISA-03 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
1/3 
1/3 
1/3 
1/3 
CF-ISU4 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
CF-1su• 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
TABLE 3 COMPARISON OF HNT BETWEEN A. SUIS AND APP IN 
GNOTOBIOTIC TRIAL 1 
Day 
O Challenge 1 
7 
14 
21 
28 
35 
42 Challenge 2 
49 
56 
63 
71 
78 
No. positive 
A suis HNT' 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/2# 
2/3 
3/3 
3/3 
Average HNT-
A suis 
1030 
2104 
1938 
1666 
1857 
1742 
1134 
1190 
2777 
5930 
10397 
17163 
'Number of pigs positive/total number of pigs. 
# One sample was not tested. 
No. Positive APP-
HNT' Average HNT-APP 
0/3 2088 
0/3 1589 
0/3 2039 
0/3 1508 
0/3 1576 
0/3 1417 
0/3 1037 
0/3 1291 
1/3 3495 
1/3 8427 
3/3 25164 
3/3 20012 
TABLE 4 SEROLOGY GNOTOBIOTIC PIGS TRIAL 2-A. SUIS* 
Day 
o Challenge 1 
7 
14 
21 
28 
35 
42 
49 
56 Challenge 2 
63 
70 
77 
84 
91 
98 
105 
112 
119 
126 
134 
HNT 
0/8 
0/8 
0/8 
1/6.# 
4/7 
6/7 
6/7 
717 
717 
717 
6/6# 
717 
717 
717 
717 
717 
717 
717 
717 
717 
ELISA-M 
0/8 
0/8 
0/8 
on· 
0/7 
0/7 
017 
0/7 
0/7 
0/7 
0/7 
017 
0/7 
0/7 
0/7 
0/7 
0/7 
0/7 
017 
017 
'Number of pigs positive/total number of pigs. 
1 Hemolysin Neutralization Titer-Kansas State University. 
2APP 5 ELISA-University of Montreal. 
3APP 5 ELISA-Oxford Laborato~ies. 
4APP 5 Complement Fixation-Iowa State University. 
•one.animal died. 
#Animal'(s) sample was not tested. 
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ELISA-0 
0/8 
0/8 
0/8 
011· 
017 
0/7 
017 
0/7 
0/7 
0/7 
017 
017 
017 
0/7 
0/7 
0/7 
0/7 
0/7 
0/7 
017 
CF-ISU 
0/8 
0/8 
0/8 
011· 
0/5# 
017 
0/7 
017 
017 
017 
017 
0/7 
0/7 
0/7 
017 
0/7 
0/7 
017 
0/7 
0/7 
TABLE 5 SEROLOGY GNOTOBIOTIC PIGS TRIAL 2-APP" 
Day 
o Challenge 1 
7 
14 
21 
28 
35 
42 
49 
56 Challenge 2 
63 
70 
77 
84 
91 
98 
105 
112 
119 
126 
134 
HNT' 
0/8 
0/6. 
0/6 
0/6 
0/6 
0/6 
1/6 
2/6 
6/6 
6/6 
6/6 
6/6 
6/6 
6/6 
6/6 
6/6 
6/6 
6/6 
6/6 
6/6 
ELISA-M2 
0/8 
015• 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
*Number of pigs positive/total number of pigs. 
1
Hemolysin Neutralization Titer-Kansas State University. 
2
APP 5 ELISA-University of Montreal. 
3 
APP 5 ELISA-Oxford Laboratories. 
4
APP 5 Complement Fixation-Iowa State University. 
•Two animals died. 
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ELISA-03 
0/8 
015• 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
CF-1su• 
0/8 
015• 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
TABLE 6 COMPARISON OF HNT BETWEEN A. SUIS AND APP IN GNOTOBIOTIC 
TRIAL2 
Day 
O Challenge 1 
7 
14 
21 
28 
35 
42 
49 
56 Challenge 2 
63 
70 
77 
84 
91 
98 
105 
112 
1_19 
126 
134 
No. Positive A suis 
HNT* 
0/8 
0/8 
0/8 
1/6+# 
4/7 
6/7 
6/7 
717 
717 
717 
6/6# 
717 
717 
717 
717 
717 
717 
717 
717 
717 
Average HNT-
A. suis 
4958 
5528 
5229 
9154 
11266 
17756 
17123 
14262 
20177 
22699 
25515 
28454 
38699 
30195 
35400 
33200 
24782 
19983 
30198 
34355 
*Number of pigs positive/total number of pigs. 
+One animal died. 
••Two animals died. 
#One sample was not tested. 
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No. Positive APP-
HNT*· Average HNT-APP 
0/8 4893 
015•• 1482 
0/6 1569 
0/6 1494 
0/6 1555 
0/6 1989 
1/6 .4047 
2/6 5797 
6/6 25012 
6/6 21366 
6/6 22287 
6/6 19094 
6/6 22686 
6/6 28364 
6/6 18344 
6/6 21443 
6/6 15618 
6/6 16205 
6/6 17842 
6/6 16094 
